Search Results - "Herkes, Geoffrey K"

Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence by Stockings, Emily, Zagic, Dino, Campbell, Gabrielle, Weier, Megan, Hall, Wayne D, Nielsen, Suzanne, Herkes, Geoffrey K, Farrell, Michael, Degenhardt, Louisa

“…Review evidence for cannabinoids as adjunctive treatments for treatment-resistant epilepsy. Systematic search of Medline, Embase and PsycINFO was conducted in…”
Get full text

Management of fingolimod-associated macular edema by Chui, Jeanie, Herkes, Geoffrey K, Chang, Andrew

Get more information

The neurologic manifestations of the acute porphyrias by Simon, Neil G, Herkes, Geoffrey K

“…Abstract The porphyrias are diseases characterised by accumulation of porphyrins and porphyrin precursors owing to enzymatic deficiencies of the haem synthetic…”
Get full text

Determining the role and responsibilities of the Australian epilepsy nurse in the management of epilepsy: a study protocol by Rapport, Frances, Hutchinson, Karen, Herkes, Geoffrey K, Bleasel, Andrew, Nikpour, Armin, Ryder, Tayhla, Wong, Chong, Bartley, Melissa, Ireland, Carol, Coleman, Honor, Todd, Lisa, Groot, Wendy, Kerr, Mike, Vagholkar, Sanjyot, Shears, Graeme, Braithwaite, Jeffrey

“…IntroductionEpilepsy is a common neurological condition affecting between 3% and 3.5% of the Australian population at some point in their lifetime. The…”
Get full text

Guillain–Barré syndrome: clinical features, treatment choices and outcomes in an Australian cohort by Barnes, Stephanie L., Herkes, Geoffrey K.

“…Background Guillain–Barré syndrome (GBS) causes acute neuromuscular weakness. Severe cases are life‐threatening and many are left disabled. Intravenous…”
Get full text

Weighty matters by Herkes, Geoffrey K

“…[...]all retrospective observational studies using data encoded medical records can be criticised on methodological grounds (incomplete ascertainment, lack of…”
Get full text

Brain histopathology in three cases of Susac's syndrome: implications for lesion pathogenesis and treatment by Hardy, Todd A, O'Brien, Billy, Gerbis, Natasha, Barnett, Michael H, Reddel, Stephen W, Brewer, Janice, Herkes, Geoffrey K, Silberstein, Paul, Garsia, Roger J, Watson, John D G, Gupta, Ruta, Parratt, John D E, Buckland, Michael E

Get full text

Risk‐adjusted hospital mortality rates for stroke: evidence from the Australian Stroke Clinical Registry (AuSCR) by Cadilhac, Dominique A, Kilkenny, Monique F, Levi, Christopher R, Lannin, Natasha A, Thrift, Amanda G, Kim, Joosup, Grabsch, Brenda, Churilov, Leonid, Dewey, Helen M, Hill, Kelvin, Faux, Steven G, Grimley, Rohan, Castley, Helen, Hand, Peter J, Wong, Andrew, Herkes, Geoffrey K, Gill, Melissa, Crompton, Douglas, Middleton, Sandy, Donnan, Geoffrey A, Anderson, Craig S

“…Objectives: Hospital data used to assess regional variability in disease management and outcomes, including mortality, lack information on disease severity. We…”
Get full text

Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case series by Smith, Jessica Louise, Menzies, Alexander M., Cohen, Justine V., Mut-Lloret, Margarida, Ozgun, Alpaslan, Spain, Lavinia, Park, John, Quach, Henry T., Pallan, Lalit, McQuade, Jennifer, Feng, Sophie, Sandhu, Shahneen, Atkinson, Victoria, Tsai, Katy, Long, Georgina V., Larkin, James, Eroglu, Zeynep, Johnson, Douglas B., Sullivan, Ryan, Herkes, Geoffrey K., Henderson, Andrew, Carlino, Matteo S.

“…Anti-programmed cell death protein 1 (PD1) antibodies, pembrolizumab and nivolumab, alone or in combination with ipilimumab, have become standard treatment for…”
Get full text

Sickle cell disease and posterior reversible leukoencephalopathy by Geevasinga, Nimeshan, Cole, Catherine, Herkes, Geoffrey K, Barnett, Yael, Lin, Jamie, Needham, Merrilee

“…Abstract Sickle cell disease can present with neurological manifestations. One such presentation is with posterior reversible leukoencephalopathy also known as…”
Get full text

Angiostrongylus meningoencephalitis: survival from minimally conscious state to rehabilitation by Blair, Nicholas F, Orr, Carolyn F, Delaney, Anthony P, Herkes, Geoffrey K

Get full text

Rationale and design of Short-Term EXenatide therapy in Acute ischaemic Stroke (STEXAS): a randomised, open-label, parallel-group study by McGrath, Rachel T, Hocking, Samantha L, Priglinger, Miriam, Day, Susan, Herkes, Geoffrey K, Krause, Martin, Fulcher, Gregory R

“…IntroductionBoth hyperglycaemia and hypoglycaemia in acute ischaemic stroke (AIS) are associated with increased infarct size and worse functional outcomes…”
Get full text

Corrigendum to: The neurologic manifestations of the acute porphyrias [18 (9) 1147–1153] by Simon, Neil G, Herkes, Geoffrey K

Get full text

7: Epilepsy by Herkes, Geoffrey K

“…Epilepsy may be associated with major social and medical problems, and counselling of patient and family is essential for good management. The workup of a…”
Get full text

Barbiturates for acute neurological and neurosurgical emergencies – do they still have a role? by Cordato, Dennis J., Herkes, Geoffrey K, Mather, Laurence E., Morgan, Michael K.

“…A number of clinical studies have reported poor clinical outcomes for patients treated with barbiturate therapy in acute neurological and neurosurgical…”
Get full text

Brief update on epilepsy treatment by Herkes, Geoffrey K

Get full text

Pharmacokinetics of Thiopental enantiomers during and following prolonged high-dose therapy by CORDATO, D. J, MATHER, L. E, GROSS, A. S, HERKES, G. K

“…Thiopental is used as a racemate; however, this is not generally recognized. During conditions of prolonged high-dose therapy, the pharmacokinetics of…”
Get full text

Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case series by Smith, Jessica Louise, Menzies, Alexander M., Cohen, Justine V., Mut-Lloret, Margarida, Ozgun, Alpaslan, Spain, Lavinia, Park, John, Quach, Henry T., Pallan, Lalit, McQuade, Jennifer, Feng, Sophie, Sandhu, Shahneen, Atkinson, Victoria, Tsai, Katy, Long, Georgina V., Larkin, James, Eroglu, Zeynep, Johnson, Douglas B., Sullivan, Ryan, Herkes, Geoffrey K., Henderson, Andrew, Carlino, Matteo S.

“…Anti-programmed cell death protein 1 (PD1) antibodies, pembrolizumab and nivolumab, alone or in combination with ipilimumab, have become standard treatment for…”
Get full text

Brain histopathology in three cases of Susac's syndrome: implications for lesion pathogenesis and treatment: Figure 1 by Hardy, Todd A, O'Brien, Billy, Gerbis, Natasha, Barnett, Michael H, Reddel, Stephen W, Brewer, Janice, Herkes, Geoffrey K, Silberstein, Paul, Garsia, Roger J, Watson, John D G, Gupta, Ruta, Parratt, John D E, Buckland, Michael E

Get full text

Effects of antiepileptic drug treatment on the background frequency of EEGs in epileptic patients by Herkes, G K, Lagerlund, T D, Sharbrough, F W, Eadie, M J

“…The effect of changing antiepileptic drug concentrations within the therapeutic range on the EEGs of epileptic subjects was studied by quantitative EEG…”
Get more information